These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 29975211
1. Choosing Between Daily and Event-Driven Pre-exposure Prophylaxis: Results of a Belgian PrEP Demonstration Project. Reyniers T, Nöstlinger C, Laga M, De Baetselier I, Crucitti T, Wouters K, Smekens B, Buyze J, Vuylsteke B. J Acquir Immune Defic Syndr; 2018 Oct 01; 79(2):186-194. PubMed ID: 29975211 [Abstract] [Full Text] [Related]
2. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence. Vuylsteke B, Reyniers T, De Baetselier I, Nöstlinger C, Crucitti T, Buyze J, Kenyon C, Wouters K, Laga M. J Int AIDS Soc; 2019 Oct 01; 22(10):e25407. PubMed ID: 31663257 [Abstract] [Full Text] [Related]
3. Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam. Hoornenborg E, Achterbergh RC, van der Loeff MFS, Davidovich U, van der Helm JJ, Hogewoning A, van Duijnhoven YT, Sonder GJ, de Vries HJ, Prins M, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative. J Int AIDS Soc; 2018 Mar 01; 21(3):e25105. PubMed ID: 29603900 [Abstract] [Full Text] [Related]
4. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, van Duijnhoven YTHP, Bruisten S, Oostvogel P, Davidovich U, Hogewoning A, Prins M, de Vries HJC, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam (H-TEAM) Initiative. Lancet HIV; 2019 Jul 01; 6(7):e447-e455. PubMed ID: 31178284 [Abstract] [Full Text] [Related]
5. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort. van den Elshout MAM, Wijstma ES, Boyd A, Jongen VW, Coyer L, Anderson PL, Davidovich U, de Vries HJC, Prins M, Schim van der Loeff MF, Hoornenborg E, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative (H-TEAM). PLoS Med; 2024 May 01; 21(5):e1004328. PubMed ID: 38718068 [Abstract] [Full Text] [Related]
6. Choosing event-driven and daily HIV pre-exposure prophylaxis - data from two European PrEP demonstration projects among men who have sex with men. Jongen VW, Reyniers T, Ypma ZM, Schim van der Loeff MF, Davidovich U, Zimmermann HM, Coyer L, van den Elshout MA, de Vries HJ, Wouters K, Smekens T, Vuylsteke B, Prins M, Laga M, Hoornenborg E. J Int AIDS Soc; 2021 Aug 01; 24(8):e25768. PubMed ID: 34382345 [Abstract] [Full Text] [Related]
7. Motives for choosing, switching and stopping daily or event-driven pre-exposure prophylaxis - a qualitative analysis. Zimmermann HM, Eekman SW, Achterbergh RC, Schim van der Loeff MF, Prins M, de Vries HJ, Hoornenborg E, Davidovich U, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Consortium (H-TEAM). J Int AIDS Soc; 2019 Oct 01; 22(10):e25389. PubMed ID: 31612621 [Abstract] [Full Text] [Related]
8. Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis-Experienced Gay and Bisexual Men in Australia. Arapali T, Grulich AE, Heywood AE, Chan C, Fraser D, Zablotska IB, Holt M, Vaccher SJ, Bavinton BR. Sex Transm Dis; 2023 Mar 01; 50(3):144-149. PubMed ID: 36730780 [Abstract] [Full Text] [Related]
9. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga JV, Goulart S, Leite IC, Freitas L, Martins LMS, Torres TS, Vasconcelos R, De Boni RB, Anderson PL, Liu A, Luz PM, Veloso VG, PrEP Brasil Study Team. Lancet HIV; 2018 Mar 01; 5(3):e136-e145. PubMed ID: 29467098 [Abstract] [Full Text] [Related]
10. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. Laurent C, Dembélé Keita B, Yaya I, Le Guicher G, Sagaon-Teyssier L, Agboyibor MK, Coulibaly A, Traoré I, Malan JB, De Baetselier I, Eubanks A, Riegel L, Rojas Castro D, Fayé-Ketté H, Koné A, Diandé S, Dagnra CA, Serrano L, Diallo F, Mensah E, Dah TTE, Anoma C, Vuylsteke B, Spire B, CohMSM-PrEP Study Group. Lancet HIV; 2021 Jul 01; 8(7):e420-e428. PubMed ID: 34048794 [Abstract] [Full Text] [Related]
11. Imperfect adherence in real life: a prevention-effective perspective on adherence to daily and event-driven HIV pre-exposure prophylaxis among men who have sex with men - a prospective cohort study in Taiwan. Wu HJ, Wen-Wei Ku S, Chang HH, Li CW, Ko NY, Strong C. J Int AIDS Soc; 2021 May 01; 24(5):e25733. PubMed ID: 34018330 [Abstract] [Full Text] [Related]
12. Trajectories of PrEP use among men who have sex with men: a pooled analysis of two prospective, observational cohort studies. Jongen VW, Reyniers T, Schim van der Loeff M, Smekens T, Hoornenborg E, van den Elshout M, Zimmermann H, Coyer L, Kenyon C, De Baetselier I, Davidovich U, de Vries HJC, Prins M, Laga M, Vuylsteke B, Boyd A. J Int AIDS Soc; 2023 Jul 01; 26(7):e26133. PubMed ID: 37501262 [Abstract] [Full Text] [Related]
13. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection. Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, Tee BK, Fairley CK, Chang CC, Armishaw J, Vujovic O, Penn M, Cundill P, Forgan-Smith G, Gall J, Pickett C, Lal L, Mak A, Spelman TD, Nguyen L, Murphy DA, Ryan KE, El-Hayek C, West M, Ruth S, Batrouney C, Lockwood JT, Hoy JF, Hellard ME, Stoové MA, Wright EJ, PrEPX Study Team. JAMA; 2019 Apr 09; 321(14):1380-1390. PubMed ID: 30964528 [Abstract] [Full Text] [Related]
14. Human Immunodeficiency Virus Seroconversion Among Men Who Have Sex With Men Who Use Event-Driven or Daily Oral Pre-Exposure Prophylaxis (CohMSM-PrEP): A Multi-Country Demonstration Study From West Africa. Laurent C, Yaya I, Cuer B, Sagaon-Teyssier L, Mensah E, Dah TTE, Coulibaly A, Kouamé MJ, Peytavin G, Serrano L, Eubanks A, Traoré I, Diallo F, Riegel L, Rojas Castro D, Dagnra CA, Anoma C, Vuylsteke B, Dembélé Keita B, Spire B, CohMSM-PrEP Study Group. Clin Infect Dis; 2023 Aug 22; 77(4):606-614. PubMed ID: 37052469 [Abstract] [Full Text] [Related]
17. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis. Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, Stoové MA. Clin Infect Dis; 2018 Aug 16; 67(5):676-686. PubMed ID: 29509889 [Abstract] [Full Text] [Related]
18. Congruence between Hypothetical Willingness to Use Pre-Exposure Prophylaxis (PrEP) and Eligibility: An Online Survey among Belgian Men Having Sex with Men. Bullinger J, Reyniers T, Vuylsteke B, Laga M, Nöstlinger C. Int J Environ Res Public Health; 2019 Nov 11; 16(22):. PubMed ID: 31718012 [Abstract] [Full Text] [Related]
19. Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use: results from the Amsterdam pre-exposure prophylaxis demonstration project. Hoornenborg E, Coyer L, van Laarhoven A, Achterbergh R, de Vries H, Prins M, van der Loeff MS, Amsterdam PrEP Project team in the HIV Transmission Elimination Amsterdam Initiative. AIDS; 2018 Jul 17; 32(11):1527-1532. PubMed ID: 29762169 [Abstract] [Full Text] [Related]